Skip to content

Clinical trials

Phase 2 Glioma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20171
20192
20203
20221
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8
Recruiting3
Completed2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Huashan Hospital3
Biotech Pharmaceutical Co., Ltd.1
First People's Hospital of Hangzhou1
HighField Biopharmaceuticals Corporation1
Kintara Therapeutics, Inc.1
Peking Union Medical College Hospital1
Sun Yat-sen University1
The Second Hospital of Hebei Medical University1
The Third Affiliated hospital of Zhejiang Chinese Medical University1
Yingjuan Zheng1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma14
Glioblastoma3
Brain Neoplasms2
Neoplasms1
Recurrence1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.